Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax^® compared with Turbuhaler^® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

References

• DecramerMAgustiAGBourbeauJCelliBRChenRCrinerGGlobal Initiative for Chronic Obstructive Lung DiseasePocket guide to COPD diagnosis, management and prevention Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Pocket_2015_Feb18.pdfAccessed July 4, 2016
   Google Scholar
• de Miguel DiezJCarrasco GarridoPGarcía CarballoMDeterminants and predictors of the cost of COPD in primary care: a Spanish perspectiveInt J Chron Obstruct Pulmon Dis20083470171219281084
   PubMedGoogle Scholar
• MasaJFSobradilloVVillasanteCJiménez-RuizCAFernández-FauLViejoJLMiravitllesMCostes de la EPOC en EspañaEstimación a partir de un estudio epidemiológico poblacional. [Cost of chronic obstructive pulmonary disease in Spain. Estimation from a population-based epidemiological study]Arch Bronconeumol20044027279 Spanish14746730
   PubMed Web of Science ®Google Scholar
• MiravitllesMSorianoJBGarcía-RíoFPrevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activitiesThorax20096486386819553233
   PubMed Web of Science ®Google Scholar
• SchulteOsseiranKBetzRWenckerMBrandPMeyerTHaidlPHandling of and preferences for available dry powder inhaler systems by patients with asthma and COPDJ Aerosol Med Pulm Drug Deliv200821432132818823257
   PubMed Web of Science ®Google Scholar
• HauptDKrigsmanKNilssonJLMedication persistence among patients with asthma/COPD drugsPharm World Sci200830550951418247154
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• MelaniASBonaviaMCilentiVInhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med201110593093821367593
   PubMed Web of Science ®Google Scholar
• MelaniASZanchettaDBarbatoNInhalation technique and variables associated with misuse of conventional metered dose inhalers and newer dry powder inhalers in experienced adultsAnn Allergy Asthma Immunol20049343944615562882
   PubMed Web of Science ®Google Scholar
• WilsonDSGillionMSReesPJUse of dry powder inhalers in COPDInt J Clin Pract200761122005200817997806
   PubMed Web of Science ®Google Scholar
• World Health OrganizationEvidence for actionGenevaWorld Health Organization2003 Adherence to long-term therapies. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed January 27, 2017
   Google Scholar
• Breekveldt-PostmaNSGerritsCMLammersJWRaaijmakersJSHeringsRMPersistence with inhaled corticosteroid therapy in daily practiceRespir Med200498875275915303640
   PubMed Web of Science ®Google Scholar
• BenderBGPedanAVarastehLTAdherence and persistence with fluticasone propionate/salmeterol combination therapyJ Allergy Clin Immunol2006118489990417030244
   PubMed Web of Science ®Google Scholar
• CramerJABradley-KennedyCScaleraATreatment persistence and compliance with medications for chronic obstructive pulmonary diseaseCan Respir J2007141252917315055
   PubMed Web of Science ®Google Scholar
• LokkeAAhlbeckLBjermerLExpert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung diseaseEur Clin Respir J201522944526689215
   PubMed Web of Science ®Google Scholar
• LaubeBJanssensHde JonghFWhat the pulmonary specialists should know about the new inhalation therapiesEur Respir J20113761308133121310878
   PubMed Web of Science ®Google Scholar
• Boletín Oficial Del EstadoCanonicaGWArpJKeegstraJRChrystynHSpiromax, a new dry powder inhaler: dose consistency under simulated real-world conditionsJ Aerosol Med Pulm Drug Deliv2015285309319 Spanish26352860
   PubMed Web of Science ®Google Scholar
• Orden SSI/2160/2015, October 17th, where public prices were updated Available from: https://www.boe.es/boe/dias/2015/10/17/pdfs/BOE-A-2015-11177.pdfAccessed November, 2015
   Google Scholar
• SorianoJBMiravitllesMBorderíasLDiferencias geográficas en la prevalencia de EPOC en España relación con hábito tabáquico, tasas de mortalidad y otros determinantes. [Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors]Arch Bronconeumol20104610522530 Spanish20832926
   PubMed Web of Science ®Google Scholar
• Generalitat Valencia [webpage on the Internet]Conselleria de Sanitat. Plan de salud en EPOC de la Comunitat Valenciana 2010–2014. [Health Counseling. COPD Health Plan in the Valencian Community 2010–2014] Available from: http://docplayer.es/9127129-Plan-de-salud-en-epoc-de-la-comunitat-valenciana-2010-2014.htmlAccessed April 1, 2015
   Google Scholar
• Instituto Nacional de Estadístico (INE) [webpage on the Internet]Proyecciones de población a corto plazo. 2011–2021. [Short-term projects of population 2011–2012] Available from: http://www.ine.es/jaxi/menu.do?type=pcaxis&path=%2Ft20%2Fp269%2F2011-2021&file=pcaxis&L=Accessed January, 2015 Spanish
   Google Scholar
• AncocheaJMiravitllesMGarcía-RíoFMuñozLSánchezGSobradilloVInfradiagnóstico de la enfermedad pulmonar obstructiva crónica en mujeres: cuantificación del problema, determinantes y propuestas de acción. [Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions]Arch Bronconeumol201349223229 Spanish23317767
   PubMed Web of Science ®Google Scholar
• AzouzWChetcutiPHoskerHSaralayaDChrystynHInhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax and Turbuhaler devices: a randomised, cross-over studyBMC Pulm Med2015154725927483
   PubMed Web of Science ®Google Scholar
• MiravitllesMMurioCGuerreroTGisbertRCost of chronic bronchitis and COPD. A one year follow-up studyChest200312378479112628879
   PubMed Web of Science ®Google Scholar
• BOT PlusBase de Datos de Medicamentos del Consejo General de Colegios Farmacéuticos. [Drug Database of the General Council of Pharmaceutical Colleges.] Bot Plus 2 – Portalfarma Available from: https://botplusweb.portalfarma.com/Accessed April 12, 2015 Spanish
   Google Scholar
• Junta de AndalucíaOrden de 14 de octubre de 2005, por la que se fijan los precios públicos de los servicios sanitarios prestados por Centros dependientes del Sistema Sanitario Público de Andalucía. [Order of 14 October 2005 establishing public prices of services provided by health centres under the Public Health System of Andalusia] Available from: http://www.juntadeandalucia.es/boja/2005/210/28Accessed April 5, 2015 Spanish
   Google Scholar
• Resolució SLT 353/2013. DOGC Núm 6326. 13/02/2013 Available from: www.comb.cat/Upload/Documents/4635.PDFAccessed April 5, 2015 Spanish
   Google Scholar
• Madrid Autonomous CommunityOrden 731/2013, de 6 de septiembre, del Consejero de Sanidad, por la que se fijan los precios públicos por la prestación de los servicios y actividades de naturaleza sanitaria de la Red de Centros de la Comunidad de Madrid. [Order 731/203, of September 6, of the Adviser of Health, for which public prices are set for the provision of health services and activities related to healthcare at the Network of Centres of the Community of Madrid] Available from: http://www.madrid.org/wleg/servlet/Servidor?opcion=VerHtml&nmnorma=8275&cdestado=PAccessed April 1, 2015 Spanish
   Google Scholar
• DIARI OFICIALLlei 14/2007, de 26 de desembre, de la Generalitat, de Mesures Fiscals, de Gestió Administrativa i Financera, i d’Organització de la Generalitat de la Comunitat Valenciana. [Law 14/2007, the 26th December, of the Government, about measures on taxes, and public management and financial from the Government of the Autonomous Community of Valencia] Available from: www.docv.gva.es/datos/2007/12/28/pdf/2007_15710.pdfAccessed April 1, 2015 Spanish
   Google Scholar
• DOGDecreto 56/2014. DOG Núm - 96 21/05/2014 Diario Oficial de la Xunta de Galicia. [Order 56/2014 DOG number 9621/05/2014 Official journal of the Government of Galicia] Available from: http://www.xunta.es/dog/Publicados/2014/20140521/AnuncioC3K1-140514-0001_es.htmlAccessed April 1, 2015 Spanish
   Google Scholar
• SALUDDecreto 25/2010, de 17 de junio, por el que se actualizan los precios públicos por actos asistenciales y servicios sanitarios prestados por la Gerencia Regional de Salud de Castilla y León. [Order 25/2010, 17th of June, to update public prices for care events and healthcare services provided by Regional Health Management of Castilla and Leon] Available from: http://www.saludcastillayleon.es/institucion/es/resumen-bocyl-legislacion-sanitaria/decreto-25-2010-17-ju-nio-actualizan-precios-publicos-actos-Accessed April 1, 2015 Spanish
   Google Scholar
• Euskadi.eusTarifas para facturación de servicios sanitarios y docentes de Osakidetza para el año 2014. [Tariffs for the invoicing of healthcare end educational services from the Basque Country Government for 2014] Available from: www.osakidetza.euskadi.eus/contenidos/.../libro_tarifas/es.../tarifas2014.pdfAccessed April 1, 2015 Spanish
   Google Scholar
• BOCServicio Canario de la Salud.- Resolución de 1 de febrero de 2013, de la Directora, por la que se modifica la cuantía de los precios públicos de servicios sanitarios previstos en el Decreto 81/2009, de 16 de junio, por el que se establecen los precios públicos de los servicios sanitarios prestados por el servicio Canario de la Salud y se fijan sus cuantías. [Healthcare service from Canary Islands. Order 1st of February 2013 from the Head of the department, which modifies public prices and set a fixed amount from healthcare services provided by the Healthcare service form Canary Islands] Available from: http://www.gobier-nodecanarias.org/boc/2013/051/001.htmlAccessed April 1, 2015 Spanish
   Google Scholar
• DerechoResolución de 03/09/2012, de la Dirección Gerencia, sobre precios a aplicar por sus centros sanitarios a terceros obligados al pago o a los usuarios sin derecho a asistencia sanitaria. [03/09/2015 resolution of the Management Board, on prices to apply by their health centres to users without the right to health care;2012/12714] Available from: http://legislacion.derecho.com/resolucion-03-09-2012-13-setiembre-2012-servicio-de-salud-de-castilla-la-mancha-sescam-4473664Accessed April 1, 2015 Spanish
   Google Scholar
• ASESORÍA & EMPRESAOrden de 5 de febrero de 2013 de la Consejería de Economía y Hacienda, por la que se publican las tarifas de las tasas y precios publicos aplicables en el 2013. [Order of February 5, 2013 of the Adviser of Economy and Finance, for which the rates of fees and public prices are set to be applicable in 2013] Available from: http://portaljuridico.lexnova.es/legislacion/JURIDICO/188905/orden-de-5-de-febrero-de-2013-de-la-consejeria-de-economia-y-hacienda-por-la-que-se-publican-las-tAccessed April 1, 2015 Spanish
   Google Scholar
• Saludinforma.esResolución de 30 de julio de 2012, de la Dirección Gerencia del Servicio Aragonés de Salud, sobre revisión de las tarifas a aplicar por la prestación de servicios sanitarios a terceros obligados al pago o a usuarios sin derecho a asistencia sanitaria en la Comunidad Autónoma de Aragón. [Resolution of 30 July 2012 management of Aragon Health Service on revision of tariffs to be applied for the provision of health services to users without the right to health care in the Autonomous Community of Aragon] Available from: https://www.saludinforma.es/portalsi/web/salud/servicios-prestaciones/modificaciones-aseguramiento/legislacion;jsessionid=UO8tW+KzATD4PEs6Bza5XtWd.mov-saludinforma-01Accessed April 1, 2015 Spanish
   Google Scholar
• Caib.esConsejería de Salud, Familia y Bienestar Social. Núm. 4814. Resolución del director general del Servicio de Salud de modificación de los anexos 1 y 2 de la Orden de la consejera de Salud y Consumo de 22 de diciembre de 2006. [Ministry of Health, Family and Social Welfare. No. 4814. Resolution of the General Director of Health Service amending Annexes 1 and 2 of the Order of the Minister of Health and Consumption of December 22, 2006] Available from: http://www.caib.es/eboibfront/es/2012/7826Accessed April 1, 2015 Spanish
   Google Scholar
• LewisABlackneyMTorvinenSThe budget impact of Duoresp® Spiromax® (budesonide+ formoterol fumarate dihydrate) compared with Symbicort® Turbohaler® for the management of asthma and chronic obstructive pulmonary disease in the United Kingdom: impact on health care costs and inhalation techniqueValue Health2014177A591
   Web of Science ®Google Scholar
• TorvinenSNicolaiJPulimenoSThe budget impact of Duoresp® Spiromax® compared with commonly prescribed dry powder inhalers for the management of asthma and chronic obstructive pulmonary disease in Italy: estimated impact of inhalation techniqueValue Health2015187A496
   Web of Science ®Google Scholar
• NicolaiJTorvinenSHowardDJMilesRGreaneyMHComberiatiUPlichAThe budget impact of an inhaler with improved features compared to Spiriva® Handihaler® for the management of chronic obstructive pulmonary disease (COPD) in the UK: estimated impact on unscheduled healthcare costs and inhaler satisfactionValue Health2015187A497
   Web of Science ®Google Scholar
• FroisCWuEQRaySColiceGLInhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterolClin Pharmacol Ther2009311227792803
   Google Scholar
• CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
   PubMed Web of Science ®Google Scholar
• RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis20083337138418990964
   PubMedGoogle Scholar
• LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
   PubMed Web of Science ®Google Scholar
• CanonicaGWArpJKeegstraJRChrystynHSpiromax, a new dry powder inhaler: dose consistency under simulated real-world conditionsJ Aerosol Med Pulm Drug Deliv201528530931926352860
   PubMed Web of Science ®Google Scholar
• MäkeläMJBackerVHedegaardMLarssonKAdherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespir Med2013107101481149023643487
   PubMed Web of Science ®Google Scholar
• ChapmanKRVoshaarTHVirchowJCInhaler choice in primary practiceEur Respir Rev20051496117122
   Google Scholar
• TaffetGDonohueJAltmanPConsiderations for managing chronic obstructive pulmonary disease in the elderlyClin Interv Aging20149233024376347
   PubMed Web of Science ®Google Scholar
• DarbàJRamírezGGarcía-RiveroJLA budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regionsClinicoecon Outcomes Res2016843544427660476
   PubMedGoogle Scholar